| Literature DB >> 24493670 |
Heiko Becker1, Kenichi Yoshida, Nadja Blagitko-Dorfs, Rainer Claus, Milena Pantic, Mahmoud Abdelkarim, Christoph Niemöller, Christine Greil, Björn Hackanson, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Satoru Miyano, Konstanze Döhner, Susanne Schnittger, Philipp Henneke, Charlotte M Niemeyer, Christian Flotho, Dietmar Pfeifer, Seishi Ogawa, Michael Lübbert.
Abstract
We describe the development of acute myeloid leukemia (AML) in an adult with CBL syndrome caused by a heterozygous de novo germline mutation in CBL codon D390. In the AML bone marrow, the mutated CBL allele was homozygous after copy number-neutral loss-of-heterozygosity and amplified through a chromosomal gain; moreover, an inv(16)(p13q22) and, as assessed by whole-exome sequencing, 12 gene mutations (eg, in CAND1, NID2, PTPRT, DOCK6) were additionally acquired. During complete remission of the AML, in the presence of normal blood counts, the hematopoiesis stably maintained the homozygous CBL mutation, which is reminiscent of the situation in children with CBL syndrome and transient juvenile myelomonocytic leukemia. No additional mutations were identified by whole-exome sequencing in granulocytes during complete remission. The study highlights the development of AML in an adult with CBL syndrome and, more generally, in genetically aberrant but clinically inconspicuous hematopoiesis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24493670 DOI: 10.1182/blood-2013-10-533844
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113